Perspectives Archives - Insights
Skip to Content MayoACCESS MayoLINK...
MLS Students Under the Microscope Archives - Insights
Skip to Content MayoACCESS MayoLINK...
Breast Pathology Services at Mayo Clinic Laboratories
Given our case volume, we've developed a special expertise in those rare variants of carcinoma, where the diagnosis is essential. Learn more.
New Year's Specimen Shipping Guidelines and Schedule - Insights
Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered for the New Year's holiday. To ensure specimen viability and minimize delays, the following adjustments and guidelines have been implemented and will be...
U N ITED STATES C O U RIER SH IPPIN G G U ID E TRANSPORTING SPECIMENS WITHIN THE UNITED STATES 2 | UNITED STATES SHIPPING GUIDE THIS GUIDE HAS BEEN DEVELOPED TO MEET THE FOLLOWING OBJECTIVES: • Provide instructions for packaging...
newborn-screen-follow-up-elevated-c3-dc-isolated.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 05/2023 Newborn screen result: Isolated elevation of malonylcarnitine (C3-DC) Perform: Blood gas, glucose, electrolytes Order: ■ OAU / Organic Acids Screen,...
search - Mayo Clinic Laboratories
Search Results Site Search...
Staffing to Workload in Phlebotomy Areas: Minimum Staffing Levels - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, discusses staffing to workload in phlebotomy areas with a focus on minimum-staffing levels, which can override the calculated staffing needs by adding staff to meet potential demands.
May 2023 - Oral Pathology - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Oral Pathology.
RNA test identifies large B-cell lymphoma subtypes: Lisa Rimsza, M.D. - Insights
Lisa Rimsza, M.D., explains how Mayo Clinic Laboratories' unique PM3CX test can accurately determine subtypes of large B-cell lymphoma. Precise diagnosis is critical to choosing appropriate chemotherapy.